Vector-borne diseases (VBDs) represent a significant public health challenge in India, with rising incidence and expanding geographic distribution. This article provides a comprehensive overview of this issue, focusing on the epidemiology, prevention strategies, and future directions for healthcare professionals.
India bears a significant burden of VBDs, including malaria, dengue, and chikungunya, among others. Changing environmental conditions, increased urbanization, and population movement have led to the spread of vectors, contributing to the increased incidence of these diseases.
Combating VBDs requires a multi-faceted approach. Preventive measures include vector control, use of personal protective equipment, and community education. Additionally, early diagnosis and prompt treatment are crucial. The role of healthcare professionals extends beyond clinical management to include community engagement and health education.
Despite efforts, several challenges persist in controlling VBDs. These include a lack of robust surveillance systems, inadequate public health infrastructure, and socioeconomic factors. The complex lifecycle of vectors and the development of resistance to insecticides and drugs further complicate control efforts.
Addressing the rising challenge of VBDs in India necessitates strengthening health systems, improving surveillance, and investing in research to develop new tools and strategies. Intersectoral collaboration and community participation are also vital. As healthcare professionals, our role is pivotal in this endeavor.
Vector-borne diseases pose a significant threat to public health in India. As healthcare professionals, we must stay abreast of the latest developments, actively participate in prevention efforts, and advocate for stronger health systems. Together, we can contribute to reducing the burden of VBDs in India.
1.
Innovative oncology therapeutics are being created in collaboration between Moderna and Immatics.
2.
A higher risk of chemotherapy-induced peripheral neuropathy is associated with a deficiency in vitamin D prior to treatment.
3.
New imaging guidelines for head and neck cancers, a step toward practice change
4.
How wildfires pose challenges to cancer care
5.
Annual whole-body, low-dose CT aids management of smoldering multiple myeloma
1.
Checkpoint Inhibitors in Oncology: Advances in PD-1/PD-L1 and CTLA-4 Targeted Therapy
2.
Mitoxantrone–Napabucasin Co-Nanoformulation Activates cGAS-STING in HCC Therapy
3.
Geriatric Medicine Through Long-Term Functional Survivorship After Cancer in Older Adults
4.
Omentum Cancer: Causes, Symptoms, and Treatment Options
5.
Advanced Directions in Oncology and Quality Improvement
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
When Unexplained Bruising May Require Blood Testing
2.
Current Scenario of Cancer- The Incidence of Cancer in Men
3.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part I
4.
Efficient Management of First line ALK-rearranged NSCLC - Part IV
5.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation